Khurshid R. Ghani, MB, BCh, MS

Course Director
Associate Professor of Urology
University of Michigan


After receiving his medical degree from the University of Leeds, Dr. Ghani trained in urology in Edinburgh and London. He also has a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of his sub-specialist training in endourology and stone disease at Guys Hospital, London, he undertook a minimally invasive urologic surgery fellowship at Henry Ford Hospital, Detroit. He joined the University of Michigan faculty in 2013, and oversees the Endourology program at the Ann Arbor VA. Dr. Ghani has authored over 100 peer-reviewed publications and is the editor of Endourology: A Practical Handbook. He is the Course Director of the “Developments in Ureteroscopic Stone Treatment (DUST)” course, which focuses on the Dusting technique for laser stone surgery. Dr. Ghani is also the Co-Director of the Michigan Urological Surgery Improvement Collaborative, statewide consortium of over 40 urology practices focused at improving urological care in the state of Michigan.

William W. Roberts, M.D.

Course Co-Director
Professor of Urology
Chief, Division of Endourology
University of Michigan


William W. Roberts, MD is Professor of Urology and Biomedical Engineering at the University of Michigan. He earned a B.S. in Physics from the Massachusetts Institute of Technology in 1992, an M.D. from the Johns Hopkins University School of Medicine in 1997, and completed his urology training at the Brady Urological Institute at Johns Hopkins. He joined the faculty of the University of Michigan in 2004 and is Director of the Division of Endourology. His clinical practice is focused on minimally invasive surgery, endourology, and urinary stone disease.

Dr. Roberts is part of the multidisciplinary scientific team at the University of Michigan that developed histotripsy, a non-invasive, focused ultrasound technology that induces controlled cavitation to mechanically ablate targeted tissues within the body. He is the director of the Endourology Translational Research Laboratory which is focused on optimization and safety of laser lithotripsy.

Dr. Roberts has presented his work at international and national meetings and has authored over 115 peer-reviewed publications. His research contributions have been recognized in the form of multiple grants and awards from the National Institutes of Health, American Urological Association Foundation, Coulter Foundation, Engineering and Urology Society, and Industry partners. He was the 2014 recipient of the prestigious AUA Gold Cystoscope Award.

Ralph Clayman, MD

Keynote Speaker
Distinguished Professor
Endowed Chair in Endourology
Dean – Emeritus
University of California – Irvine


Dr. Ralph V. Clayman is a graduate of Grinnell College and the University of California – San Diego, School of Medicine. Following his residency in Urology at the University of Minnesota, he completed an AUA research scholarship at the University of Texas – Southwestern studying cholesterol metabolism in renal cell cancer. He then spent 17 years at Washington University in St. Louis; attaining the rank of Professor of Urology and Radiology. In 1984, he initiated the first fellowship program in Endourology; more than 30 fellows have been trained, many of whom have current leadership positions in academic urology. In 1990, he and his surgical team (Dr. Louis Kavoussi and Dr. Nat Soper) performed the world’s first laparoscopic nephrectomy. In January 2002, he became the Chair of the newly formed Department of Urology at the University of California – Irvine; within four years, the department was listed among the top 20 programs in the country. In 2009, he became Dean of the School of Medicine at UC Irvine, serving a 5-year term during which time the school of medicine attained full accreditation from the LCME, achieved a positive financial balance, opened over 750,000 square feet of new space, and initiated the first totally tablet based medical school curriculum. In 2016, he published a book regarding academic leadership entitled, “The Compleat Dean” which has sold over 1,000 copies.

Dr. Clayman is a co-founder of the Endourology Society and continues to serve as co-editor of the Journal of Endourology. He holds 13 patents on devices/instruments used in minimally invasive surgery and has published over 400 peer reviewed manuscripts. Presently he is a Distinguished Professor of Urology in the Department of Urology at UC Irvine and occupies an endowed Chair in Endourology. He has an active clinical practice in urolithiasis and co-directs the endourology research laboratory and endourology fellowship program at UC Irvine.


Thomas Knoll, MD

Associate Professor of Urology
Mannheim University Hospital

Head of Urology
Sidfelfingen Medical Center


Dr. Thomas Knoll is Associate Professor of Urology at Mannheim University Hospital, Germany, and Head of the Department of Urology, Sindelfingen Medical Center, University of Tuebingen, Germany. Dr. Knoll was previously staff member and Head of Endourology and Minimal-invasive surgery at the Department of Urology, University Hospital Mannheim, Germany. Dr. Knoll’s field of expertise includes endourologic, laparoscopic and robotic surgery for urolithiasis, benign prostatic hyperplasia and uro-oncology.

His extensive scientific and clinical work focuses on the interventional treatment of urolithiasis and benign hyperplasia. He performed a large experimental work on the pathogenesis and prevention of calcium oxalate and cystine stone formation.

Dr. Knoll won a total of 9 awards pertaining to his innovation and research, including the Arthur-Smith-Award of the Endourology Society, the best abstract in stone disease of the American Urological Association (AUA), the 2nd best experimental abstract of the European Association of Urology (EAU) and the Felix-Martin-Oberländer Award of the German Urological Society (DGU)

Dr. Knoll has published over 140 manuscripts in peer-reviewed literature and 16 book chapters.

Dr. Knolls serves an Editorial board member of the Journal of Endourology, the World Journal of Urology, and Urolithiasis. He is board member of the EAU Guideline Office, the Sections for Urolithiasis, Uro-Technology and Ethics in Live Surgery. In 2015 he was appointed as Member of the EAU Scientific Committee.

Juan Manuel López Martínez, MD

Fundació Puigvert


Dr. Juan Manuel López Martínez graduated in Medicine and Surgery from the Autonomous University of Madrid (2006). He specialized via MIR in Urology at the Fundació Puigvert in Barcelona, receiving the Prize for the best communication from the Catalan Society of Urology in the last year of residence. It has the accreditation for laparoscopic surgery of the European Association of Urology (E-BLUS exam).

He has participated as a speaker in different courses and congresses at national and international level, receiving different awards (Prize for the best communication-video of surgical technique in urology from the Spanish Society of Laparoscopic Surgery 2012, Prize for the best communication-video of surgical technique of the Catalan Society of Urology 2012).

He has published several articles in national and international magazines on bladder and kidney tumors. Currently, he is part of the Spanish research group for Chronic Bladder Pain of the Spanish Association of Urology.

He is currently an adjunct doctor in the Functional Urology and Pelvic Floor Unit at the Fundació Puigvert, where he also collaborates with the Kidney Transplant Unit.

Kandarp Parikh, M. Ch DNB (Urology)

Shyam Urosurgical Hospital


Dr. Kandarp Parikh is a senior practicing Urologist at Ahmedabad for more than 20 years. He serves as a Chairman of Shyam Urosurgical Hospital and Consultant of the Department of Urology and Kidney Transplant Sterling Hospital, Ahmedabad.

Dr. Kandarp is a well sought after speaker and has been invited faculty for many conferences and meetings worldwide. He is a world renowned faculty in the field of Flexible ureteroscopy. He has been a regular faculty in World Endourology conferences (Mumbai, Amsterdam, Munich, Taiwan & London). He has been invited to the ESD in South Africa and Dubai. He was also part of the Segura course at Qatar. In last two years he has conducted international RIRS workshops at Turkey, Nepal & Bangladesh. He has been a operating faculty at the Pre conference workshop of USICON 2015,2016 and 2017, WZUSICON, SZUSICON & NZUSICON-2016. He has also conducted live operative workshops in Kota, Indore, PGI Chandigarh, Agra, Mehsana , Bhopal and Guwahati etc.

Dr. Kandarp Parikh is pioneer in bringing newer technologies in urology for the benefit of needy patients. He has enormous contributions in the field of Laser prostate surgeries (Holep, Greeen light Laser ) , Laparoscopic and Robotic uro onco surgeries.

Dr. Kandarp is an academician who has organized many major conferences in the zone. To name a few: Minimal Access Surgery 2003, WZUSICON, USICON 2004, AIE 2013 & 2016. Apart from these, Dr. Kandarp runs The Minimal access training institute at Shyam Urosurgical Hospital. Many Urologists from India and neighboring country have participated in this program.

Dr. Kandarp has been associated with Urology society for many years in various positions. He started as a council member in 2003-05 then rose to be treasurer in 2011-13 and then continued as an honorary Secretary for last four years. He has also been the secretary of the Ahmedabad Urology Association (2001-03) and the founding secretary of the Gujarat Urology Association (2009-12).

Daron Smith
MA, BM, BCh, MD, FRCS(Urol)

King Edwards VII’s Hospital


Mr Richard Daron Smith (known as Daron) qualified with a first class honours degree in Medical Sciences from Gonville and Caius College, Cambridge before moving to New College, Oxford for his clinical training at the John Radcliffe Hospital.

Before embarking on specialist training in Urology, he completed his MD at Imperial College supported by a prestigious grant from the British Urological Foundation.

Mr Smith was trained in general urology in West London, and gained subspecialist training in EndoUrology at St Mary’s Hospital, Guy’s Hospital and at the Institute of Urology at UCH. He was appointed as a Consultant Urological Surgeon to Imperial NHS trust in 2007, and moved to the Stone and EndoUrology unit at UCH in 2009.

In addition to general Urology, Dr Smith’s sub-specialist practice is primarily the comprehensive management of Urinary Tract Stone disease. He also treats other upper tract abnormalities, including strictures, extrinsic obstruction, and the endoluminal management of upper tract TCC. He teaches on a number of specialist stone / endourology skills courses, and runs a general course for younger urology trainees that he developed when a trainee himself. He is also part of the London Urology Specialists.

Kay Thomas, MD

Consultant, Urological Surgeon
National Health Service, London


Kay Thomas qualified from Charing Cross and Westminster Medical School, London in 1994. She trained in the London Area and did her MD thesis as a Research Fellow at the Royal College of Surgeons of England. In 2006 she was appointed as a consultant post at Guy’s and St Thomas’ NHS Foundation Trust where currently she is also a Deputy Medical Director.

Her specialist interest is Endourology with a particular focus on cystinuria and upper tract TCC with the following achievements;

– Developed, validated and published the Guy’s Stone Score which is a measure of stone complexity for PCNL and is in the BAUS National Benchmarking Audit.

– Established the cystinuria clinic at Guy’s over 10 years ago where over 200 patients have been seen and the work has been published/presented both Nationally and Internationally.

– Developed a method of using Bouins to improve the interpretation of ureteroscopic biopsies which was been adopted by the National Pathology Guidelines. Part of a multidisciplinary team specifically managing upper tract TCC.

– Disease Area Co-ordinator for Stones in the eUROGEN European Reference Network (ERN).

– In addition she is a faculty member of the EAU Urolithiasis Guidelines and the NICE Renal and Ureteric Stone Guidelines.


Sapan Ambani, M.D.

Assistant Professor of Urology
Associate Residency Program Director of Urology
University of Michigan


Dr. Ambani is a native mid-Michigander, having grown up in Jackson, MI. After receiving his undergraduate degree from Harvard University, he obtained his medical degree from the University of Pittsburgh School of Medicine. He subsequently completed his Urology residency at the University of Michigan, and then stayed on to complete a fellowship in Laparoscopy, Robotics, and Stone Surgery. He subsequently joined the Endourology division of the University of Michigan Health System Department of Urology. His clinical interests include minimally-invasive surgery of the kidney and ureter, including ureteropelvic junction (UPJ) obstruction and complex ureteral reconstruction using small incisions, kidney masses, and kidney stone surgery. He also serves as the Associate Residency Program Director. He serves as the head of the University of Michigan Ureteral Reconstruction Working Group, which aims to improve the care of patients who require ureteral reconstruction surgery through clinical collaboration and research. Based on this work, he has a shared appointment in the division of Neurourology and Pelvic Reconstruction within the Department of Urology.

Brian Eisner, M.D.

Co-Director, Kidney Stone Program
Assistant Professor of Surgery
Havard Medical School


Dr. Brian Eisner is the Co-Director of the Kidney Stone Program at the MGH. He specializes in kidney stone surgery, kidney stone prevention and related research.

Dr. Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones, and laparoscopic surgery. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease and surgical treatment of kidney stones.

Chad Ellimooti, M.D.

Assistant Professor of Urology
University of Michigan


Chad Ellimoottil is an Assistant Professor at the University of Michigan and a member of the Institute for Healthcare Policy and Innovation. After graduating with a degree in Economics from Northwestern University, Dr. Ellimoottil worked at the Medicare Payment Advisory Commission. He subsequently completed medical school and urology residency at Loyola University Medical Center. During his residency, he completed a master’s degree in Health and Healthcare Research through the Rackham Graduate School at University of Michigan. He is currently a urologist at the University of Michigan, the Director of Telehealth for the Urology Department and a member of Michigan Medicine’s eHealth Business Infrastructure team. Dr. Ellimoottil’s research agenda is focused on evaluating telehealth programs and policies. He also directs the Telehealth Research Incubator. He has over 60 scientific publications and has received multiple grants for research. He has received multiple awards for clinical care and research including Michigan Medicine’s “Making a Difference Award”, Loyola University’s Magis Star for Excellent Patient Care, HCUP’s Outstanding Article of the Year Award and American Urological Association North Central Section Young Health Policy Investigator Award.

Bobo Knudsen, MD

Director, Comprehensive Kidney Stone Program
The Ohio State University Wexner Medical Center


Dr. Bodo Knudsen a urologist, with a major focus on the management of kidney stones. At The Ohio State University Wexner Medical Center, he performed more than 500 surgeries a year related to kidney stones. Research at the Comprehensive Kidney Stone Program ties directly to his clinical program. Dr. Knudsen explores new treatments for kidney stones including medications and surgical techniques. He also studies the use of lasers in the treatment of stones. Dr. Knudsen’s goal is to personalize the health care delivered to each patient. He works with his patients to develop individualized treatment plans. Effective treatment of stones can provide relief of an acutely painful episode and also reduce future stone recurrences. Such treatment can significantly improve a patient’s quality of life.

Amy Krambeck, MD

Michael O. Koch Professor of Urology
Indiana University School of Medicine


Dr. Amy Krambeck is the Michael O. Koch Professor of Urology at Indiana University School of Medicine in Indianapolis, Indiana. Her Urology residency was completed at the Mayo Clinic in Rochester, Minnesota in 2008. Subsequently, from 2008 to 2009 she participated in an Endourology fellowship at the Methodist Institute for Kidney Stone Research in Indianapolis, Indiana. From 2009 to 2016 she worked as an Endourologist in the Mayo Clinic Department of Urology, then joined the staff at Indiana University in July of 2016. Dr. Krambeck specializes in the surgical and medical treatment of stone disease and benign prostatic hyperplasia. Her research interests include the pathogenesis of stone disease and the treatment of urolithiasis during pregnancy.

Michael Lipkin, M.D., MBA

Associate Professor Urologic Surgery
Chief of the Clinics, Department of Surgery
Duke University Medical Center


Dr. Lipkin received his medical degree from New Jersey Medical School in 2003. He completed his urology residency at New York University Medical Center in 2009. In 2011, he completed an Endourology and Minimally Invasive Urologic Surgery Fellowship with Dr. Glenn Preminger at Duke University Medical Center. His main clinical and academic interests are in the surgical and medical management of kidney stones. His particular research focus is in patient radiation exposure and urologic imaging. He has over 30 peer-reviewed manuscripts and has co-authored several chapters. He was awarded for Best of AUA for an abstract on stone disease in 2012. He also was awarded for Best Endourology Presentation at the World Congress of Endourology in 2012.

Nicole Miller, MD

Assistant Professor
Department of Urology
Vanderbilt University Medical Center


Dr. Nicole Miller currently holds the position of Associate Professor of Urology at Vanderbilt University School of Medicine in Nashville, TN. She joined the department in 2007. She completed her M.D. degree at the University of Pittsburgh School of Medicine in 2000, and received her urology residency training at the University of Virginia. Dr. Miller went on to complete a 2 year fellowship in Endourology and Minimally Invasive Surgery at the Indiana University School of Medicine under the mentorship of Dr. James E. Lingeman. She specializes in the medical and surgical treatment of kidney stone disease as well as laser surgery for BPH. Dr. Miller’s research interests include investigation of Randall’s plaque in the pathophysiology of nephrolithiasis, new laser technologies for kidney stone and BPH treatment, novel platforms for BPH surgery and investigation of pathophysiologic pathways for refractory BPH/LUTS. She has been the major contributor of transition zone prostate tissues from men undergoing surgery for refractory BPH/LUTS as part of Vanderbilt University’s Biorepository in the Center for Benign Urologic Diseases (CBUD) and has co-authored work on this developing resource. She has served as course faculty member and moderator both nationally and internationally for the American Urological Association and Endourological Society in the area of surgical treatment of BPH and nephrolithiasis. Dr. Miller is an Editorial Board Member for the Journal of Urology, Journal of Endourology and Co-director of the Minimally Invasive Surgery and Endourology Fellowship at Vanderbilt University Medical Center. She also served as a member of the AUA guidelines panel for the Surgical Management of Nephrolithiasis and AUA Leadership Class of 2017.

Ojas Shah, MD

George F. Cahill Professor of Urology
Director of the Division of Endourology and Stone Disease
Columbia University Irving Medical Center


Dr. Ojas Shah is the George F. Cahill Professor of Urology at Columbia University College of Physicians and Surgeons. He also serves as the Director of the Division of Endourology and Stone Disease at Columbia University Medical Center. He is a graduate of the Honors Program in Medical Education at Northwestern University School of Medicine. He completed his general surgical and urologic training at New York University Medical Center. He spent an additional year at Wake Forest University Health Sciences Center as a fellow in endourology, laparoscopy and metabolic stone disease.

His clinical and research interests include surgical and metabolic treatments of kidney stone disease, minimally invasive urologic surgery, upper urinary tract urothelial carcinoma (transitional cell carcinoma), ureteral strictures, ureteropelvic junction (UPJ) obstruction, ureteral/renal reconstructive surgery, and BPH (benign prostate hyperplasia). He serves as the principal investigator in many clinical research trials regarding the surgical or medical management of stone disease. Dr. Shah serves as the Director of the Endourology Fellowship at Columbia University Medical Center. He additionally has a strong focus on medical student and resident education, and served as the urology residency program director at NYU School of Medicine prior to joining Columbia.

Dr. Shah recently served as a member of the American Urological Association’s Surgical Management of Stones Guidelines Committee. He is also a member of the American Board of Urology’s Examination Committee. He is an active member of the Endourological Society, EDGE (Endourology Disease Group for Excellence) Research Consortium, and ROCK (Research on Calculous Kinetics) Society. Dr. Shah was recently an Assistant Editor for the Journal of Urology, the most highly cited and amongst the most respected international journals in the field. He is also co-editor of the 5th Edition of Taneja’s Complications of Urologic Surgery which was released in 2018.